These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13973373)

  • 1. [Clinical contribution to the therapeutic action and tolerance to rifomycin B and SV in pediatrics].
    RAZZI A
    G Mal Infett Parassit; 1962 Sep; 14():523-5. PubMed ID: 13973373
    [No Abstract]   [Full Text] [Related]  

  • 2. [RIFOMYCIN SV IN LABORATORY TESTS].
    NINNI A
    Arch Tisiol Mal Appar Respir; 1963 Oct; 18():919-44. PubMed ID: 14097338
    [No Abstract]   [Full Text] [Related]  

  • 3. [OBSERVATIONS ON TOLERANCE TO THE INTRASPINAL INTRODUCTION OF RIFAMYCIN SV].
    VERGA G; ZANETTI G
    Chemotherapia (Basel); 1963; 10():660-2. PubMed ID: 14184806
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE ROUTES AND METHODS OF ADMINISTRATION OF RIFAMYCIN SV. THE TOLERANCE OF THE BODY].
    NITTI V
    Chemotherapia (Basel); 1963; 12():482-91. PubMed ID: 14185774
    [No Abstract]   [Full Text] [Related]  

  • 5. [RIFAMYCIN SV IN THE THERAPY OF HUMAN PULMONARY TUBERCULOSIS].
    GRASSI C; BASILICO F
    Chemotherapia (Basel); 1963; 12():526-32. PubMed ID: 14185779
    [No Abstract]   [Full Text] [Related]  

  • 6. [ACTIVITY OF RIFAMYCIN SV IN THE TREATMENT OF TUBERCULOSIS].
    TACQUET A
    Chemotherapia (Basel); 1963; 12():492-500. PubMed ID: 14185775
    [No Abstract]   [Full Text] [Related]  

  • 7. [CLINICAL TOLERANCE OF RIFAMYCIN SV ADMINISTERED BY VENOUS PERFUSION. (RESEARCH ON THE USE OF SOLUTIONS CONTAINING OR WITHOUT POLYVINYLPYRROLIDONE AND ON THE ASSOCIATION WITH PARA-AMINOSALYCILIC ACID)].
    NINNI A; GALDIERI R
    Arch Tisiol Mal Appar Respir; 1964 Oct; 19():832-56. PubMed ID: 14265719
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifomycin IX. Two new antibiotics of rifomycin family: rifomycin S and rifomycin SV. Preliminary report.
    SENSI P; TIMBAL MT; MAFFII G
    Experientia; 1960 Sep; 16():412. PubMed ID: 13750122
    [No Abstract]   [Full Text] [Related]  

  • 9. [FURTHER EXPERIMENTAL INVESTIGATIONS ON THE TOLERANCE, ABSORPTION AND ELIMINATION OF RIFAMYCIN SV AND SOME OF ITS NEW PREPARATIONS].
    CURCI G
    Chemotherapia (Basel); 1963; 257():176-85. PubMed ID: 14098247
    [No Abstract]   [Full Text] [Related]  

  • 10. [LOCAL ADMINISTRATION OF RIFAMYCIN SV IN OTORHINOLARYNGOLOGY].
    DECROIX G; DEGUINES C
    Chemotherapia (Basel); 1963; 10():606-11. PubMed ID: 14184797
    [No Abstract]   [Full Text] [Related]  

  • 11. [LEVELS OF RIFAMYCIN SV IN THE AQUEOUS HUMOR AND ITS TOLERANCE AFTER SUBCONJUNCTIVAL ADMINISTRATION IN THE RABBIT].
    ALFONSO G
    Chemotherapia (Basel); 1963; 10():577-85. PubMed ID: 14184791
    [No Abstract]   [Full Text] [Related]  

  • 12. [PERIANAL FISTULA OF PHLEBITIC ORIGIN TREATED WIT TOPICAL APPLICATION OF RIFOMYCIN SV. PRACTICAL CONTRIBUTION].
    SACINO G
    Gazz Med Ital; 1964 May; 123():150-2. PubMed ID: 14171779
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility to rifomycin B and SV of antibiotic resistant staphylococci.
    COCCHI P; GAMBASSINI L
    Chemotherapia (Basel); 1962; 4():530-4. PubMed ID: 14021861
    [No Abstract]   [Full Text] [Related]  

  • 14. [CONTROLLED CLINICAL TESTS OF TOLERANCE WITH PREPARATIONS FOR INTRAMUSCULAR USE].
    SACCHETTI G; ROBOTTI E
    Clin Ter; 1964 Jun; 29():442-50. PubMed ID: 14173215
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical contribution to trial use of rifomycin SV].
    DI LORENZO S
    G Mal Infett Parassit; 1962 Sep; 14():518-22. PubMed ID: 14027553
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifomycin. XIV. Production of rifomycin B.
    MARGALITH P; PAGANI H
    Appl Microbiol; 1961 Jul; 9(4):325-34. PubMed ID: 13766661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LOCAL USE OF RIFOMYCIN-SV (RF-SV) IN PULMONARY TUBERCULOSIS. PRELIMINARY COMMUNICATION].
    CUCCHIANIACEVEDO R; LERNER S; FIORINO AR; IRURZUN A
    Arch Argent Tisiol Neumonol; 1963; 39():159-63. PubMed ID: 14126676
    [No Abstract]   [Full Text] [Related]  

  • 18. [Local tolerance, absorption and elimination of rifomycin SV (experimental observations in laboratory animals and research in man)].
    CURCI G; NINNI A
    Arch Tisiol Mal Appar Respir; 1961 Dec; 16():1079-123. PubMed ID: 13882674
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of the therapeutic activity of rifomycin SV in the treatment of biliary tract infections].
    ACOCELLA G; BARONI GC; MUSCHIO R
    G Mal Infett Parassit; 1962 Sep; 14():556-9. PubMed ID: 14010897
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifomycin SV in the treatment of prolonged jaundice in childhood].
    MASTELLA G; MONTENOVESI P
    G Mal Infett Parassit; 1962 Sep; 14():525-31. PubMed ID: 13933471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.